Analyst firms · Raymond James · HUM

Raymond James HUM price target and rating history

Humana Inc. (HUM) · Health Care

Raymond James rates Humana Inc. (HUM) Outperform with a $520 price target, as of its latest action on Oct 12, 2026. It has published 4 rating actions on HUM since March 2024, including 2 upgrades and 1 downgrade. Across 13 firms with a HUM price target in the last 12 months, the median target is $500. Raymond James's $520 is 4% above that.

Current rating
Outperform
Price target
$520
Median target, all firms
$500
Actions on HUM
4

Raymond James price target on HUM

$520$418$3152026
Raymond James price target on HUM, each point a stated target, May 2025 to October 2026.

Every Raymond James rating on HUM

How other firms rate HUM

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
TD CowenBuy$485Nov 20, 2026
RBC Capital MarketsOutperform$563Nov 16, 2026
Raymond JamesOutperform$520Oct 12, 2026
Robert W. BairdOutperform$596Oct 9, 2026
Cantor FitzgeraldOverweight$460Oct 7, 2026
BarclaysOverweight$515Sep 25, 2026
Morgan StanleyEqual-Weight$370Aug 5, 2026
Evercore ISIOutperform$480Jul 30, 2026
Leerink PartnersOutperform$513Jul 30, 2026
BofA SecuritiesBuy$500Jul 29, 2026
Wells FargoOverweight$502Jul 13, 2026
Deutsche BankBuy$441May 20, 2026
JefferiesBuy$313Dec 5, 2025

Questions about Raymond James and HUM

What is Raymond James's price target for HUM?
Raymond James's latest stated price target for Humana Inc. (HUM) is $520, from its action on Oct 12, 2026.
What is Raymond James's rating on HUM?
Raymond James rates HUM Outperform, a bullish rating, as of Oct 12, 2026.
When did Raymond James last change its view on HUM?
On Oct 12, 2026, Raymond James upgrades to Outperform from Mkt Perform, price target $520.
How does Raymond James's HUM target compare with other analysts?
Across 13 firms with a HUM price target in the last 12 months, the median target is $500. Raymond James's $520 is 4% above that.

More HUM rating histories

All Raymond James ratingsHUM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.